We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $1.67B Turnover 44.44%
1-Year Est. Return 1.43%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
-1.43%
3 Year Est. Return
-6.61%
5 Year Est. Return
-27.23%
10 Year Est. Return
–
AUM
$1.67B
AUM Growth
-$505M
Cap. Flow
-$520M
Cap. Flow %
-31.03%
Top 10 Hldgs %
29.21%
Holding
171
New
21
Increased
23
Reduced
68
Closed
55
Avg Time Held Equity + Options
1.1 years
Top 10 Avg Time Held Equity + Options
0.6 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
1.1 years
Top 10 Avg Time Held Equity only
0.6 years
Top 20 Avg Time Held Equity only
0.8 years

Top Sells

Rank Stock Value
1
CHRD icon
Chord Energy
CHRD
+$73.2M
2
TFX icon
Teleflex
TFX
+$52.2M
3
AKAM icon
Akamai
AKAM
+$46.6M
4
RNG icon
RingCentral
RNG
+$30.2M
5
HAE icon
Haemonetics
HAE
+$28.8M

Sector Composition

Rank Sector Weight
1 Technology 32.19%
2 Healthcare 19.57%
3 Industrials 14.44%
4 Consumer Discretionary 10.33%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
COTY icon
126
Coty
COTY
$2.77B
– –
-714,212
Closed -$1.44M –
EAF icon
127
GrafTech
EAF
$190M
– –
-99,312
Closed -$673K –
ECVT icon
128
Ecovyst
ECVT
$1.1B
– –
-418,265
Closed -$5.38M –
ETSY icon
129
Etsy
ETSY
$8.26B
– –
-87,679
Closed -$4.38M –
FFWM icon
130
DELISTED
First Foundation Inc
FFWM
– –
-1,051,878
Closed -$6.21M –
HLF icon
131
Herbalife
HLF
$1.52B
– –
-89,773
Closed -$1.32M –
HSTM icon
132
HealthStream
HSTM
$1.03B
– –
-240,370
Closed -$4.98M –
JACK icon
133
Jack in the Box
JACK
$243M
– –
-125,915
Closed -$1.22M –
JBSS icon
134
John B. Sanfilippo & Son
JBSS
$779M
– –
-73,886
Closed -$5.86M –
JILL icon
135
J. Jill
JILL
$365M
– –
-194,318
Closed -$2.23M –
LAZ icon
136
Lazard
LAZ
$3.54B
– –
-256,750
Closed -$10.9M –
LEG icon
137
DELISTED
Leggett & Platt
LEG
– –
-2,158,533
Closed -$21.3M –
MANH icon
138
Manhattan Associates
MANH
$13.2B
– –
-50,679
Closed -$6.75M –
MG icon
139
Mistras Group
MG
$661M
– –
-452,614
Closed -$6.69M –
MLR icon
140
Miller Industries
MLR
$582M
– –
-114,896
Closed -$5.23M –
OPRX icon
141
OptimizeRx
OPRX
$166M
– –
-229,370
Closed -$1.44M –
OVV icon
142
Ovintiv
OVV
$18.3B
– –
-153,463
Closed -$9.11M –
OXM icon
143
Oxford Industries
OXM
$414M
– –
-123,740
Closed -$4.77M –
PCTY icon
144
Paylocity
PCTY
$8.82B
– –
-85,938
Closed -$9.28M –
PII icon
145
Polaris
PII
$3.03B
– –
-87,768
Closed -$4.78M –
PINS icon
146
Pinterest
PINS
$12.7B
– –
-343,104
Closed -$6.29M –
PRAA icon
147
PRA Group
PRAA
$743M
– –
-407,398
Closed -$7.13M –
PRPL icon
148
Purple Innovation
PRPL
$9.46M
– –
-20,000
Closed -$331K –
PYPL icon
149
PayPal
PYPL
$48.6B
– –
-154,819
Closed -$7M –
QDEL icon
150
QuidelOrtho
QDEL
$967M
– –
-76,267
Closed -$1.25M –

Similar funds

Invenomic Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Invenomic Capital Management held 171 positions worth $1.67B, down 23% from $2.18B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Invenomic Capital Management withdrew a net $520M in Q2 2026, closing 55 positions and reducing 68 holdings. Its most notable exit was Chord Energy, an estimated $73.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Invenomic Capital Management opened a new position in Charter Communications worth $40.2M.

  • Invenomic Capital Management's largest Q2 2026 buy was Charter Communications: 282,416 shares worth $40.2M.
  • Invenomic Capital Management added most to Universal Health Services in Q2 2026, an estimated $39.4M increase.
  • Invenomic Capital Management's biggest Q2 2026 reduction was Haemonetics, cutting an estimated $28.8M.
  • Invenomic Capital Management fully exited Chord Energy in Q2 2026, selling an estimated $73.2M.
  • Invenomic Capital Management's ten largest holdings make up 29% of its $1.67B portfolio in Q2 2026.
  • Invenomic Capital Management opened 21 new positions and closed 55 in Q2 2026.
  • Invenomic Capital Management's portfolio value fell 23% quarter-over-quarter to $1.67B.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.